ASN
Advisory Services Network’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-200
| Closed | -$7.2K | – | 1848 |
|
|
2023
Q1 | $7.2K | Hold |
200
| – | – | ﹤0.01% | 3006 |
|
|
2022
Q4 | $8.91K | Buy |
+200
| New | +$8.91K | ﹤0.01% | 2907 |
|
|
2021
Q3 | – | Sell |
-17
| Closed | -$1K | – | 1725 |
|
|
2021
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3431 |
|
|
2021
Q1 | – | Sell |
-17
| Closed | – | – | 1621 |
|
|
2020
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 3361 |
|
|
2020
Q3 | $0 | Buy |
+17
| New | – | ﹤0.01% | 3554 |
|
|
2020
Q2 | – | Sell |
-17
| Closed | – | – | 1321 |
|
|
2020
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 3061 |
|
|
2019
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 3100 |
|
|
2019
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 2805 |
|
|
2019
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 2818 |
|
|
2019
Q1 | $0 | Sell |
17
-253
| -94% | – | ﹤0.01% | 2542 |
|
|
2018
Q4 | $0 | Buy |
270
+10
| +4% | – | ﹤0.01% | 2539 |
|
|
2018
Q3 | $0 | Hold |
260
| – | – | ﹤0.01% | 2510 |
|
|
2018
Q2 | $0 | Hold |
260
| – | – | ﹤0.01% | 2493 |
|
|
2018
Q1 | $1K | Hold |
260
| – | – | ﹤0.01% | 2452 |
|
|
2017
Q4 | $1K | Hold |
260
| – | – | ﹤0.01% | 2432 |
|
|
2017
Q3 | $1K | Hold |
260
| – | – | ﹤0.01% | 2255 |
|
|
2017
Q2 | $1K | Hold |
260
| – | – | ﹤0.01% | 2202 |
|
|
2017
Q1 | $1K | Buy |
+260
| New | +$1K | ﹤0.01% | 2061 |
|
|
2016
Q2 | – | Sell |
-85
| Closed | – | – | 1845 |
|
|
2016
Q1 | $0 | Hold |
85
| – | – | ﹤0.01% | 1686 |
|
|
2015
Q4 | $1K | Hold |
85
| – | – | ﹤0.01% | 1417 |
|
|
2015
Q3 | $1K | Buy |
+85
| New | +$1K | ﹤0.01% | 1402 |
|